Literature DB >> 26551921

Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits.

Sónia Campos1,2,3, Joaquim Monteiro4,5, Belén Valenzuela6,7, Helena Gonçalinho8, Paula Guedes de Pinho3, Paula Fresco8, Luis Félix2, Luís Antunes1,2.   

Abstract

Propofol is an anaesthetic widely used in both human beings and animals. However, the characterization of propofol pharmacokinetics (PK) is not well understood when long-term infusions are used. The main objective of this study was to explore the PK behaviour of propofol in a rabbit model during short and prolonged propofol infusions and to develop an internally validated PK model, for propofol dose individualization in the rabbit for future use. Population 1 (P1) was constituted by seven New Zealand rabbits and was used to characterize the PK profile of propofol at short infusions. Animals were anaesthetized with a bolus of 20 mg/kg, followed by an infusion rate of 50 mg/kg/hr of propofol at 1%, which was then maintained for 30 min. A second rabbit population (P2, n = 7) was sedated according to reflexes responses and Index of Consciousness values, for 20 consecutive hours using propofol 2% aiming at characterizing propofol behaviour at long-term infusions. Clinical data and blood samples were collected at specific time-points in both populations. Propofol plasma concentrations were determined by gas chromatography/ion trap mass spectrometry. The NONMEM VII software was used to evaluate the relationships between dose and plasma concentrations. A linear two-compartment model with different central compartment volume and plasma clearance (separately modelled in the two populations) was the one that best described propofol concentrations. The time course of propofol plasma concentrations was well characterized by the PK model developed, which simultaneously accounts for propofol short- and long-term infusions and can be used to optimize future PK studies in rabbits.
© 2015 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26551921     DOI: 10.1111/bcpt.12521

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  5 in total

1.  In vivo study of hepatic oxidative stress and mitochondrial function in rabbits with severe hypotension after propofol prolonged infusion.

Authors:  Sónia Campos; Luís Félix; Carlos Venâncio; Maria de Lurdes Pinto; Francisco Peixoto; Paula Guedes de Pinho; Luís Antunes
Journal:  Springerplus       Date:  2016-08-15

2.  Development and validation of brain target controlled infusion of propofol in mice.

Authors:  Brenna P Shortal; Sarah L Reitz; Adeeti Aggarwal; Qing C Meng; Andrew R McKinstry-Wu; Max B Kelz; Alex Proekt
Journal:  PLoS One       Date:  2018-04-23       Impact factor: 3.240

3.  JM-1232(-) and propofol, a new combination of hypnotics with short-acting and non-cumulative preferable properties.

Authors:  Saori Taharabaru; Takahiro Tamura; Michiko Higashi; Naoyuki Matsuda; Maiko Satomoto; Yushi U Adachi; Aiji Boku Sato; Masahiro Okuda
Journal:  Exp Anim       Date:  2020-10-16

4.  Modeling propofol-induced cardiotoxicity in the isolated-perfused newborn mouse heart.

Authors:  Matthew B Barajas; Aili Wang; Keren K Griffiths; Linlin Sun; Guang Yang; Richard J Levy
Journal:  Physiol Rep       Date:  2022-08

5.  The influence of storage time and temperature on propofol concentrations in canine blood and plasma.

Authors:  Sherry Cox; Joan Bailey; Chika Okafor; Reza Seddighi; Tom Doherty
Journal:  PeerJ       Date:  2017-06-30       Impact factor: 2.984

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.